Concorde Lift
by Medos International SARL 2 variants
510(k) K171425
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK171425 | Date20 Jul 2017 | StatusActive |
Recalls
-
- Terminated Z-1225-2019
A complaint trend was observed for post-operative loss of height and migration for Concorde Lift G3+ implants.
-
- Terminated Z-0848-2018
Potential for Intra-operative breakage of driver tips
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- MAX
- Device class
- Class II
- Regulation
- 21 CFR Part 888.3080
- Advisory committee
- Orthopedic
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 27 Sep 2026
The Concorde Lift is an expandable interbody device used in spinal fusion procedures. It is designed to be implanted via posterior, transforaminal, or lateral approaches to treat discogenic back pain with disc degeneration confirmed by history and radiographic studies in skeletally mature patients who have undergone a six-month course of conservative treatment.
The device is supplied as a sterile, single-use implant and has received FDA 510(k) clearance under K171425. It is intended for use in orthopedic spinal surgery and is regulated as a Class II medical device. No MRI safety information, storage conditions, or additional sizes are specified in the provided data.